Immunovant, Inc. IMVT Total debt
Discontinued — last reported Q4 '26
Total debt at other companies
Other financials
Where this comes from
Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $72K.
The official record: Immunovant, Inc.’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunovant, Inc.'s total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immunovant, Inc.'s total debt?
- Immunovant, Inc. (IMVT) reported total debt of $72K in Q1 2026.
- How has Immunovant, Inc.'s total debt changed year-over-year?
- Immunovant, Inc.'s total debt decreased by 26.5% year-over-year, from $98K to $72K.
- What is the long-term trend for Immunovant, Inc.'s total debt?
- Over 5 years (2021 to 2026), Immunovant, Inc.'s total debt has grown at a -53.8% compound annual growth rate (CAGR), from $3.42M to $72K.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.